Gene · 63973
NEUROG2: neurogenin 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NEUROG2: neurogenin 2. Genes, record 63973. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/63973
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9H2A3 | Neurogenin-2 | 272 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents55
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4801417 A1 | 2026-09-09 | 1 | Q9H2A3 | Espacenet |
| WO 2026048797 A | 2026-03-05 | 2 | Q9H2A3 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15357 | Q9H2A3 | Espacenet |
| JP 2025122659 A | 2025-08-21 | 2 | Q9H2A3 | Espacenet |
| WO 2025120143 A1 | 2025-06-12 | 41 | Q9H2A3 | Espacenet |
| EP 4524243 A1 | 2025-03-19 | 13 | Q9H2A3 | Espacenet |
| JP 2025032187 A | 2025-03-11 | 8 | Q9H2A3 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15357 | Q9H2A3 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15357 | Q9H2A3 | Espacenet |
| KR 1020250009964 A | 2025-01-20 | 13 | Q9H2A3 | Espacenet |
1 to 10 of 55
See all 55 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,125
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NEUROG2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA014195 | Cancer Center Support Grant (CCSG) | 12 | 2025 |
| P50HD105351 | Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center | 10 | 2025 |
| R01MH106575 | Systematic Functional Interpretation of Regulatory Variants in Neuropsychiatric Disorders | 10 | 2025 |
| R01AG055909 | Probing Heterogeneity of Alzheimer's Disease Using iPSCs | 9 | 2025 |
| ZIANS003155 | Mechanisms of inherited neurodegenerative diseases | 8 | 2025 |
| P01AG019724 | Frontotemporal Dementia: Genes, Images, and Emotions | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| R01AA023797 | Cellular and genomic mechanisms of the impact of ethanol on human neural model | 5 | 2025 |
| R01MH123155 | Functional convergence following disruption of diverse genes associated with neurodevelopmental disorders | 5 | 2025 |
1 to 10 of 2,125Source NIH's project files
See all 2,125 nih grantsPapers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-associated enzymes are mislocalized to the cytoplasm in iPSC-derived neurons, resulting in KRAB(KOX1)-specific degradation. | Cell Syst | 2026 | 42777717 | PubTator, text mining | PubMed |
| Self-amplifying RNA enables rapid, durable, integration-free programming of hiPSCs. | Cell Rep Methods | 2026 | 42748925 | PubTator, text mining | PubMed |
| TRANsCre-DIONE transdifferentiates scar-forming reactive astrocytes into functional motor neurons. | Exp Mol Med | 2026 | 42722703 | PubTator, text mining | PubMed |
| Regenerative potential of von Hippel-Lindau tumor suppressor protein. | World J Biol Chem | 2026 | 42707860 | PubTator, text mining | PubMed |
| Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development. | J Cell Biol | 2026 | 42704317 | PubTator, text mining | PubMed |
| Basic principles for astrocyte-to-neuron conversion. | Neural Regen Res | 2026 | 42667625 | PubTator, text mining | PubMed |
| Direct neuronal reprogramming for neurological diseases: applications, translational Challenges, and future directions. | Front Neurosci | 2026 | 42630431 | PubTator, text mining | PubMed |
| Optimization of a neuron-microglia co-culture model to explore cell-to-cell interaction dynamics. | Front Immunol | 2026 | 42568588 | PubTator, text mining | PubMed |
| Navigating Human Astrocyte Differentiation: Direct and Rapid One-Step Differentiation of Induced Pluripotent Stem Cells to Functional Astrocytes Supporting Neuronal Network Development. | Glia | 2026 | 42452972 | PubTator, text mining | PubMed |
| CRISPR-engineered deletion of POGZ alters transcription factor binding at promoters of genes involved in synaptic signaling. | HGG Adv | 2026 | 42433021 | PubTator, text mining | PubMed |
1 to 10 of 2,160
See all 2,160 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/63973
GET https://conductscience.org/api/genes/v1/63973/patents?page=2